Mobia Medical (MOBI) analyst forecast and price target
Analyst forecast
Consensus of 4 analyst ratings
Based on 4 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| BTIG | Maintained | Buy | $19.00 | Aug 12, 2026 |
| JP Morgan | Maintained | Overweight | $17.00 from $15.00 | Aug 12, 2026 |
| JP Morgan | Initiated Coverage | Overweight | $15.00 | Jun 2, 2026 |
| BTIG | Initiated Coverage | Buy | $19.00 | Jun 2, 2026 |
| Goldman Sachs | Initiated Coverage | Buy | $31.00 | Jun 2, 2026 |
| B of A Securities | Initiated Coverage | Buy | $16.00 | Jun 2, 2026 |
Frequently asked questions
What is the price target for MOBI stock?
The average 12-month analyst price target for Mobia Medical (MOBI) is $20.75, with a high estimate of $31.00 and a low of $16.00, across 4 analysts.
Is MOBI a buy, sell, or hold?
Analysts covering Mobia Medical currently average a Buy rating: 4 buy, 0 hold and 0 sell, from 4 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for MOBI?
The average price target of $20.75 implies 86.10% upside from the last price of $11.15.
What is the latest analyst rating on MOBI?
On Aug 12, 2026, BTIG maintained Mobia Medical at Buy with a price target of $19.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.